Abstract
The production and manufacture of vaccines against rabies for veterinary use using technology already developed for human use, of the type rabies antigen in adhered BHK cells, is aimed at increasing global productivity in response to new market demands. This involves a relevant technological innovation for the country, insofar as it will create the conditions for a significant increase in…